Product Information
AMLODIPINE-ATORVAST 2.5-10 MG is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $3.0799 per EA under NDC 62332075530. Its NADAC has been published 33 times since Sep 10, 2025.
FDA first approved this application on May 22, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5; 10 mg/1; mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332075530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA217279FDA Approved
5/22/2025
TE Code
AB
On Market Since
5/23/2025
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 2.5-10 MG has been published 33 times since Sep 10, 2025, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0799 per EA |
|---|---|
| All-time high | $3.5039 (Jan 14, 2026) |
| All-time low | $3.0799 (May 20, 2026) |
| 52-week high | $3.5039 |
| 52-week low | $3.0799 |
| Median price | $3.5039 |
| Average price | $3.3241 |
| Largest weekly change | -12.1% (May 20, 2026) |
| Weeks tracked | 33 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 2.5-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 2.5-10 MG, manufactured by Alembic Pharmaceuticals Inc., is $3.0799 per EA (NDC 62332075530), effective Aug 19, 2026.
How has the price of AMLODIPINE-ATORVAST 2.5-10 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 2.5-10 MG has declined 12.1%. It has been tracked across 33 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 2.5-10 MG?
Since Sep 10, 2025, the NADAC for AMLODIPINE-ATORVAST 2.5-10 MG has ranged from a low of $3.0799 (May 20, 2026) to a high of $3.5039 (Jan 14, 2026), with a median of $3.5039 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 2.5-10 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 2.5-10 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 2.5-10 MG?
AMLODIPINE-ATORVAST 2.5-10 MG (NDC 62332075530) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.